However, conflicting results preclude confirming a definitive relationship between the intensity of PSMA PET/CT uptake, the grade of ccRCC lesions, and the presence of unfavorable pathological features. This evidence concerns the gene FOLH1 and nonpapillary renal cell carcinoma.